11/7
07:12 am
zyme
Zymeworks Inc. (NYSE: ZYME) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $25.00 price target on the stock, up previously from $10.00.
Medium
Report
Zymeworks Inc. (NYSE: ZYME) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $25.00 price target on the stock, up previously from $10.00.
11/7
07:09 am
zyme
Rating for ZYME
Medium
Report
Rating for ZYME
11/4
11:56 am
zyme
Rating for ZYME
Medium
Report
Rating for ZYME
11/4
11:56 am
zyme
Rating for ZYME
Medium
Report
Rating for ZYME
11/1
08:15 am
zyme
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/1
07:46 am
zyme
Zymeworks Inc. (NYSE: ZYME) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $12.00 price target on the stock.
Low
Report
Zymeworks Inc. (NYSE: ZYME) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $12.00 price target on the stock.
11/1
07:23 am
zyme
Rating for ZYME
Low
Report
Rating for ZYME
11/1
07:23 am
zyme
Rating for ZYME
Low
Report
Rating for ZYME
10/28
09:52 am
zyme
Rating for ZYME
Low
Report
Rating for ZYME
10/22
08:32 am
zyme
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
9/18
08:05 am
zyme
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.